Riskpilot← Back to searchSign inGet full accessImaGene - iT AB
ABActiveOrg 5568864267Scheelevägen 2 Medicon VillageResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20120 employees
Revenue 2024
SEK 2,4M
-38% vs 2023
EBITDA margin
-10.2%
-98% vs 2023
Equity ratio
19.1%
Financial strength
Net profit 2024
SEK -390K
-60% vs 2023
| Revenue | SEK 2,4M | -38% |
| EBITDA | SEK -247K | -98% |
| Net profit | SEK -390K | -60% |
| Total assets | SEK 964K | -41% |
| Equity | SEK 184K | -68% |
| Employees | 0 | — |
Legal name
ImaGene - iT AB
Org number
5568864267
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
5 mars 2012
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom klinisk sjukdomsdiagnostik, bioteknik, läkemedelsutveckling, specifikt inriktad på \imaging\, d.v.s. framställning, behandling och analys av bilddata och relaterad datorstödd informationsteknik, samt därmed förenlig verksamhet.
Address
Scheelevägen 2 Medicon Village
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 458 | 4 432 | 4 746 | 3 880 | 2 414 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 332 | 455 | 299 | −125 | −247 |
| Depreciation & amort. | −225 | −234 | −230 | −78 | −75 |
| EBIT | 107 | 221 | 69 | −203 | −322 |
| Net financials | −74 | −58 | −44 | −40 | −68 |
| Profit before tax | 34 | 121 | 67 | −244 | −390 |
| Tax | −8 | −26 | −16 | −0 | −0 |
| Net profit | 26 | 95 | 51 | −244 | −390 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 427 | 2 314 | 2 297 | 1 623 | 964 |
| Equity | 671 | 766 | 818 | 574 | 184 |
| Long-term debt | 1 211 | 918 | 733 | 582 | 495 |
| Short-term debt | 545 | 588 | 746 | 467 | 285 |
| Total debt | 1 756 | 1 506 | 1 479 | 1 049 | 780 |
EBITDA margin
-10.2%
This company
15.8%
Market median
-165% vs market
20202024
Equity ratio
19.1%
This company
38.2%
Market median
-50% vs market
20202024
Return on equity
-212.0%
This company
18.4%
Market median
-1252% vs market
20202024
Net profit margin
-16.2%
This company
8.1%
Market median
-300% vs market
20202024
Asset turnover
2.50×
This company
1.12×
Market median
+123% vs market
20202024
Debt / equity
4.24×
This company
0.62×
Market median
-584% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NA Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
| Audit | 2022 – 2025 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ImaGene - iT AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birger Ola Mattias Kristensson | Audit | 0 companies |
| Nils Anders Brinte | Chief Executive Officer | 0 companies |
| Bo Ingvar Holmqvist | Chairman | 0 companies |
| Aviva Suskin Holmqvist | Board of Directors | 0 companies |